Announcement pursuant to rule 13.10 of the listing rules
Filed with HKEX · Stock code 1548 · · 2 pages · English
This announcement is made by Genscript Biotech Corporation (the “Company,” together with its subsidiaries, the “Group”) at the request of The Stock Exchange of Hong Kong Limited (the ‘‘Stock Exchange’’) pursuant to Rule 13.10 of the Rules Governing the Listing of Securities on the Stock Exchange. The board of directors of the Company (the “Board”) has noted the increase in the price and trading vo
Genscript Biotech Corporation on 6ix
Earlier from Genscript Biotech
- List of directors and their role and function
- Passing away of an independent non-executive director and change in composition of board committees
- Interim report 2026
- Next Day Disclosure Return
- Completion of placing of new shares under the general mandate
Later from Genscript Biotech
- Change in board lot size
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement: legend announces preliminary sales for CARVYKTI for the quarter ended 30 September 2026
Follow Genscript Biotech into a list and get an email when it puts out news.
Follow Genscript Biotech